BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32395507)

  • 1. Is a simplified TNM staging system more clinically relevant than the American Joint Committee on Cancer system for the follicular variant of papillary thyroid cancer?
    Hu D; Huang Y; Zeng W; Chen S; Huang Y; Li M; Long W; Huang J; Wei W; Zhang C; Liu Z; Guo L
    Ann Transl Med; 2020 Apr; 8(7):463. PubMed ID: 32395507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
    Yang F; Zhong Q; Huang Z; Lian M; Fang J
    Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
    [No Abstract]   [Full Text] [Related]  

  • 3. New proposed tumor-node-metastasis staging system for medullary thyroid carcinoma based on the Surveillance, Epidemiology, and End Results database.
    Wang M; Hu D; Zeng W; Chen S; Huang Y; Zhou L; Zhou W; Wei W; Zhang C; Liu Z; Guo L
    Am J Transl Res; 2020; 12(6):2703-2710. PubMed ID: 32655802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rethinking the 8th AJCC System: Is It Suitable for Patients Aged <55 Years With Stage T4N1M0 Follicular Variant of Papillary Thyroid Carcinoma to Be Placed in Stage I?
    Long W; Hu D; Zhou L; Huang Y; Zeng W; Chen S; Huang Y; Li M; Wang M; Zhou W; Huang J; Wei W; Zhang C; Liu Z; Guo L
    Front Oncol; 2020; 10():543055. PubMed ID: 33425716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer.
    Adam MA; Thomas S; Roman SA; Hyslop T; Sosa JA
    JAMA Surg; 2017 Sep; 152(9):869-876. PubMed ID: 28636692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newly proposed survival staging system for poorly differentiated thyroid cancer: a SEER-based study.
    Sun W; Wang Z; Xiang J; Qin Y; Zhang F; Zhang H
    J Endocrinol Invest; 2023 May; 46(5):947-955. PubMed ID: 36484934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOES T STAGE AFFECT PROGNOSIS IN PATIENTS WITH STAGE IV B DIFFERENTIATED THYROID CANCER?
    Li M; Trivedi N; Dai C; Mao R; Wang Y; Ning Y; Gu SZ; Huo L; Siddiqui AD
    Endocr Pract; 2019 Sep; 25(9):877-886. PubMed ID: 31170365
    [No Abstract]   [Full Text] [Related]  

  • 10. Patients Aged ≥55 Years With Stage T1-2N1M1 Differentiated Thyroid Cancer Should Be Downstaged in the Eighth Edition AJCC/TNM Cancer Staging System.
    Liu Z; Chen S; Huang Y; Hu D; Wang M; Wei W; Zhang C; Zeng W; Guo L
    Front Oncol; 2019; 9():1093. PubMed ID: 31681617
    [No Abstract]   [Full Text] [Related]  

  • 11. The impact of radioactive iodine treatment on survival among papillary thyroid cancer patients according to the 7th and 8th editions of the AJCC/TNM staging system: a SEER-based study.
    Liu X; Fan Y; Liu Y; He X; Zheng X; Tan J; Jia Q; Meng Z
    Updates Surg; 2020 Sep; 72(3):871-884. PubMed ID: 32342347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the Novel, Practical, and Prognosis-Relevant TNM Staging System for Stage I-III Cutaneous Melanoma.
    Hu D; Liu Z; Chen S; Huang Y; Zeng W; Wei W; Zhang C; Zhou L; Chen D; Wu Y; Guo L
    Front Oncol; 2022; 12():738298. PubMed ID: 35574383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma.
    Oweira H; Giryes A; Mannhart M; Decker M; Schlumpf R; Abdel-Rahman O
    Curr Med Res Opin; 2018 May; 34(5):923-929. PubMed ID: 29448859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
    Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
    Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion of the Number of Metastatic Lymph Nodes in the Staging System for Medullary Thyroid Cancer: Validating a Modified American Joint Committee on Cancer Tumor-Node-Metastasis Staging System.
    Wang Z; Tang C; Wang Y; Yin Z; Rixiati Y
    Thyroid; 2022 May; 32(5):536-543. PubMed ID: 35350868
    [No Abstract]   [Full Text] [Related]  

  • 16. A relook at the 8th edition of the AJCC TNM staging system of anaplastic thyroid carcinoma: A SEER-based study.
    Xiang J; Wang Z; Sun W; Zhang H
    Clin Endocrinol (Oxf); 2021 Apr; 94(4):700-710. PubMed ID: 33368530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified staging classification for intrahepatic cholangiocarcinoma based on the sixth and seventh editions of the AJCC/UICC TNM staging systems.
    Meng ZW; Pan W; Hong HJ; Chen JZ; Chen YL
    Medicine (Baltimore); 2017 Aug; 96(34):e7891. PubMed ID: 28834905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
    O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
    Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TUMOR SIZE IS AN INDEPENDENT PREDICTOR OF MORTALITY RISK IN DIFFERENTIATED THYROID CANCER PATIENTS WITH T4 DISEASE.
    Wang Z; Zhang Q; Ye H; Jia C; Lv Z; Liu J; Yin Z
    Endocr Pract; 2020 May; 26(5):499-507. PubMed ID: 31968190
    [No Abstract]   [Full Text] [Related]  

  • 20. A Comparison of the Seventh and Eighth Editions of the AJCC Staging Systems to Predict Recurrence in Papillary Thyroid Microcarcinoma.
    Chen Z; Ruan J; Yao Y; Wen L; Mao Z; Chen S; Zhu H; Zhao Y; Li Z; Fahey TJ; Teng L; Wang W
    Ann Surg Oncol; 2021 Oct; 28(11):6564-6571. PubMed ID: 33521903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.